Your session is about to expire
← Back to Search
Hormone Therapy + Radiation for Prostate Cancer (PCS III Trial)
PCS III Trial Summary
This trial would compare the results of two different doses of radiation therapy, given with or without hormone therapy, in order to determine which is more effective in reducing local failure rates.
PCS III Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PCS III Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- If you had cancer in the past, you can participate if you have been cancer-free for at least five years.You have severe medical or mental health issues that may make it difficult for you to follow the study requirements.
- Group 1: Arm 1
- Group 2: Arm 3
- Group 3: Arm 2
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are the findings in this research unique?
"Androgen blockade has been an active area of research for over 20 years. The first study was completed in 2000 by AstraZeneca. After this initial Phase 3 600-person study, Androgen blockade received drug approval. As of today, there are 88 ongoing Androgen blockade trials being conducted in 1523 different cities across 60 countries."
How is Androgen blockade commonly used in medical care?
"Androgen Blockade can be used to manage radiation therapy, palliative therapy, and endometrial thinning."
Does this research include elderly people as participants?
"This clinical trial is available to patients that are between 18-80 years of age."
Could I possibly qualify to help out with this research project?
"This clinical trial is looking for 600 people with prostate cancer aged 18-80 to participate. applicants must meet the following criteria: a) Patients with a previous history of cancer are eligible on the condition that they have been disease-free for more than five years, b) Patients with stage T1 or T2 untreated adenocarcinoma of the prostate, with a Gleason score that is less than or equal to 6, as well as a prostate-specific antigen (PSA) between 10-20 (intermediate risk) or patients with stage T1 or T2 untreated adenocarcinoma of the"
Is there a high risk associated with Androgen blockade therapy?
"Androgen blockade is considered to be safe (scoring a 3 on our 1-3 scale) because it has reached Phase 3 in clinical trials. This means that there is some data supporting both its efficacy and safety."
Androgen blockade has been a part of other clinical trials in the past, correct?
"As of now, there are 88 Androgen blockade clinical trials underway. Out of those, 35 are in Phase 3. Most of the Androgen blockade trials are taking place in Shijiazhuang, Hebei; however, there are 8838 locations running trials for this treatment globally."
Share this study with friends
Copy Link
Messenger